| | | Ex-BlackRock exec's firm Gallatin Point acquires First Investors, Macquarie lays off global head of TMT, other senior execs, Ex-Carlyle, Cerberus execs’ shop Staple Street holds one-and-done close | | | | Tuesday, October 13, 2020 | | | | | Morning!
Macquarie Capital laid off a number of senior executives, including David Dorfman, global head of TMT advisory, writes Milana Vinn on PE Hub today. Another departure was John Katzenmeyer, managing director on the fintech team in San Francisco, Milana wrote.
On the tech side, Macquarie is going through a banker reshuffling as it merges TMT advisory and services group to form a new software and services group. Overall, the bank has laid off more than 70 people, she wrote. Read the story here on PE Hub. |
|
| | | Top Scoops | | | Gallatin Point Capital, formed by ex-BlackRock and U.S. Treasury officials, acquired FIFS Holdings Corp, parent company to First Investors, a consumer finance company. Gallatin plans to partner with First Investors to expand its lending business and accelerate its portfolio acquisition capabilities and third-party servicing.
Matt Botein, ex-BlackRock chief investment officer and co-head of its alternatives group, and former U.S. Treasury official Lewis Sachs, launched Gallatin in 2016. Read more here on PE Hub. |
|
| | Staple Street Capital, created by former executives of Carlyle Group and Cerberus Capital in 2010, held a one-and-done final close on its third fund on $520 million. Staple Street is one of a select group of emerging managers that have been able to raise capital in the subdued fundraising environment. Read it here on Buyouts.
Have a great day! Reach me with your thoughts, tips, gossip, whatever at cwitkowsky@buyoutsinsider.com, on Twitter or find me on LinkedIn.
HOUSEKEEPING
Wanted: VCJ’s Rising Stars
It’s that time of the year. Over at Venture Capital Journal, editor Alastair Goldfisher and the team are looking for nominations for their second annual Rising Stars list. VCJ is seeking to identify the most talented and up-and-coming professionals in the venture capital community. Click here for more information on how you can submit your favorite Rising Star. | | |
|
| | | Sponsored by | | |  |
|
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Priothera lands Series A | | Dublin, Ireland-based Priothera Limited, a developer of orally applied sphingosine 1 phosphate receptor modulators for haematological malignancies, has secured 30 million euros in Series A financing. More... |
| | | | | | |
|
| To update your PE Hub email preferences, or to unsubscribe, click here. |
|  | |
|
